ORPHAN THERAPEUTICS ACCELERATOR INC
EIN 99-3630868 · Specifically Named Diseases Research (H80)
What they do
The Specific and Primary Purpose of The Orphan Therapeutics Accelerator is to Engage In Charitable and Scientific Activities Within The Meaning of Section 501(c)(3) of The Code, Including, But Not Limited To, The Following Activities: A. Providing, Expanding Access To, and Resolving Barriers to The Development of Therapeutic Resources In The Form of Drugs, Therapies, and Other Related Treatments to Rare Diseases (collectively, The "Therapies"), So As to Provide Accessible Treatments and Potential Cures to Rare Diseases That, Otherwise, Would Not Be Available (such Purposes, The "Charitable Purposes"). B. Addressing and Resolving Scientific Barriers to Development of The Therapies, Which The Accelerator Will Accomplish Via Research As It Acquires and Shepherds The Therapies Through Late-stage Clinical Trials, So As to Provide Accessible Treatments and Potential Cures for Rare Diseases Without Known and Accessible Treatments (such Purposes, The "Scientific Purposes").
Financial picture
About this charity
- Recognized since
- January 2024
- Location
- 54 Morton Street, Andover, MA 01810
- County
- Essex
- In care of
- Elizabeth White
- Primary officer
- Elizabeth White, Secretary-Executive Vice President
How to reach them
Filing and classification
- Latest tax year
- 2024
- Tax period began
- January 1, 2024
- Return type
- 990EZ
- NTEE classification
- Specifically Named Diseases Research (H80)
- IRS tax category
- Specifically Named Diseases Research
More public IRS record details
These are classification codes from the organization’s public nonprofit record.
- Subsection
- 03
- Affiliation
- 3
- Classification
- 1800
- Deductibility
- 1
- Foundation
- 15
- Organization
- 1